Clinical Report: Response Patterns of Depression Symptoms Following Dorsolateral Prefrontal rTMS Treatment
Overview
This study investigates distinct symptom-cluster response trajectories in treatment-resistant depression (TRD) patients undergoing dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation (rTMS). It highlights the heterogeneity of depression symptoms.
Background
Repetitive transcranial magnetic stimulation (rTMS) is an established treatment for individuals with treatment-resistant depression (TRD), with remission rates reported in the literature ranging from 20% to 40%. The complexity of depression, characterized by over 200 symptom combinations, necessitates a nuanced understanding of treatment responses. This study aims to explore longitudinal symptom-cluster trajectories.
Data Highlights
No specific numerical data or trial data provided in the source material.
Key Findings
rTMS is associated with differential changes across symptom clusters, with mood, insomnia, and somatic symptoms showing greater reductions than anxiety symptoms.
Depression's heterogeneity complicates treatment response, as traditional rating scales may not capture the multidimensional nature of symptoms.
Group-based multitrajectory modeling (GBMTM) can identify latent groups with similar symptom response trajectories.
Identifying co-occurring longitudinal trajectories for anxiety, mood, insomnia, and somatic symptoms may inform future research.
The study utilizes data from the THREE-D trial, a multicenter randomized noninferiority trial comparing rTMS techniques.
Clinical Implications
Understanding the distinct symptom-cluster trajectories in TRD patients can guide clinicians in tailoring rTMS treatment.
Conclusion
The findings highlight the heterogeneity of depression symptoms in rTMS treatment strategies.
by Tyler S. Kaster, Xiao Chen, Jonathan Downar, Fidel Vila-Rodriguez, Danielle A. Baribeau, Kevin E. Thorpe, Zafiris J. Daskalakis, Chao-Gan Yan, Daniel M. Blumberger
